- Home
- MRK vs CRWD Comparison
MRK vs CRWD Comparison
Compare MRK & CRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRK | CRWD |
|---|---|---|
| Founded | 2000 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.8B | 174.3B |
| IPO Year | 1995 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MRK | CRWD |
|---|---|---|
| Price | $135.44 | $217.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 48 |
| Target Price | $125.59 | ★ $507.00 |
| AVG Volume (30 Days) | 6.3M | ★ 6.6M |
| Earning Date | 04-30-2026 | 06-02-2026 |
| Dividend Yield | ★ 3.06% | N/A |
| EPS Growth | ★ 8.01 | N/A |
| EPS | N/A | ★ 0.11 |
| Revenue | ★ $65,011,000,000.00 | $4,812,005,000.00 |
| Revenue This Year | $3.61 | $24.85 |
| Revenue Next Year | $5.41 | $21.40 |
| P/E Ratio | ★ N/A | $2,050.09 |
| Revenue Growth | 1.31 | ★ 21.71 |
| 52 Week Low | $77.58 | $174.14 |
| 52 Week High | $135.68 | $786.00 |
Technical Indicators
Market Signals| Indicator | MRK | CRWD |
|---|---|---|
| Relative Strength Index (RSI) | 68.27 | 37.20 |
| Support Level | $112.68 | $177.57 |
| Resistance Level | N/A | $217.50 |
| Average True Range (ATR) | 3.32 | 8.70 |
| MACD | 0.42 | 17.20 |
| Stochastic Oscillator | 99.13 | 80.50 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About CRWD CrowdStrike Holdings Inc.
CrowdStrike is a cloud-native cybersecurity company specializing in security verticals such as endpoint, cloud workload, identity, and security operations. CrowdStrike's primary offering is its Falcon platform, which provides enterprises with a unified view to detect and respond to security threats across their IT infrastructure. The Austin, Texas-based firm was founded in 2011 and went public in 2019.